Michael E Bowen1,2, Julie A Schmittdiel3, Jeffrey T Kullgren4,5, Ronald T Ackermann6,7, Matthew J O'Brien6,7. 1. Division of General Internal Medicine, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX, 75390-9169, USA. michael.bowen@utsouthwestern.edu. 2. Division of Outcomes and Health Services Research, University of Texas Southwestern Medical Center, Dallas, TX, USA. michael.bowen@utsouthwestern.edu. 3. Kaiser Permanente Division of Research, Oakland, CA, USA. 4. VA Center for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, MI, USA. 5. University of Michigan Medical School, Ann Arbor, MI, USA. 6. Division of General Internal Medicine and Geriatrics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. 7. Northwestern University Institute for Public Health and Medicine, Chicago, IL, USA.
Abstract
PURPOSE OF REVIEW: Evidence-based treatments for prediabetes can prevent and delay the development of type 2 diabetes in adults. In this review, we propose a framework for population-based diabetes prevention that links screening and prevention activities across key stakeholders. We also discuss gaps in current practice, while highlighting opportunities to improve diabetes screening and prevention efforts population-wide. RECENT FINDINGS: Awareness of diabetes risk is low, and many adults with prediabetes are not identified through existing screening efforts. Accumulating evidence and policies support expansion of the Diabetes Prevention Program (DPP) into clinical and community settings. However, the infrastructure to facilitate referrals and promote data exchange among patients, clinical settings, and community-based DPP programs is lacking. Development of evidence-driven, scalable processes for assessing diabetes risk, screening eligible adults, and delivering preventive treatments are needed to effectively improve the glycemic health of the US adult population.
PURPOSE OF REVIEW: Evidence-based treatments for prediabetes can prevent and delay the development of type 2 diabetes in adults. In this review, we propose a framework for population-based diabetes prevention that links screening and prevention activities across key stakeholders. We also discuss gaps in current practice, while highlighting opportunities to improve diabetes screening and prevention efforts population-wide. RECENT FINDINGS: Awareness of diabetes risk is low, and many adults with prediabetes are not identified through existing screening efforts. Accumulating evidence and policies support expansion of the Diabetes Prevention Program (DPP) into clinical and community settings. However, the infrastructure to facilitate referrals and promote data exchange among patients, clinical settings, and community-based DPP programs is lacking. Development of evidence-driven, scalable processes for assessing diabetes risk, screening eligible adults, and delivering preventive treatments are needed to effectively improve the glycemic health of the US adult population.
Entities:
Keywords:
Diabetes prevention; Diabetes risk assessment; Diabetes screening; Population health
Authors: David G Marrero; Kelly N B Palmer; Erin O Phillips; Karen Miller-Kovach; Gary D Foster; Chandan K Saha Journal: Am J Public Health Date: 2016-02-18 Impact factor: 9.308
Authors: X R Pan; G W Li; Y H Hu; J X Wang; W Y Yang; Z X An; Z X Hu; J Lin; J Z Xiao; H B Cao; P A Liu; X G Jiang; Y Y Jiang; J P Wang; H Zheng; H Zhang; P H Bennett; B V Howard Journal: Diabetes Care Date: 1997-04 Impact factor: 19.112
Authors: Juleigh Nowinski Konchak; Margaret R Moran; Matthew J O'Brien; Namratha R Kandula; Ronald T Ackermann Journal: Curr Diab Rep Date: 2016-06 Impact factor: 4.810
Authors: William H Herman; George W Taylor; Jed J Jacobson; Ray Burke; Morton B Brown Journal: J Public Health Dent Date: 2015-02-06 Impact factor: 1.821
Authors: Rebecca K Simmons; Justin B Echouffo-Tcheugui; Stephen J Sharp; Lincoln A Sargeant; Kate M Williams; A Toby Prevost; Ann Louise Kinmonth; Nicholas J Wareham; Simon J Griffin Journal: Lancet Date: 2012-10-04 Impact factor: 79.321
Authors: Uma Mudaliar; Azadeh Zabetian; Michael Goodman; Justin B Echouffo-Tcheugui; Ann L Albright; Edward W Gregg; Mohammed K Ali Journal: PLoS Med Date: 2016-07-26 Impact factor: 11.069
Authors: Michael E Bowen; Zahra Merchant; Kazeen Abdullah; Deepa Bhat; Jason Fish; Ethan A Halm Journal: Health Serv Res Manag Epidemiol Date: 2017-08-29
Authors: Udoka Obinwa; Adriana Pérez; Ildiko Lingvay; Luigi Meneghini; Ethan A Halm; Michael E Bowen Journal: Diabetes Care Date: 2020-03-05 Impact factor: 19.112
Authors: Earle C Chambers; Jeffrey S Gonzalez; Melinda E Marquez; Amanda Parsons; Colin D Rehm Journal: Diabetes Educ Date: 2019-10-14 Impact factor: 2.140
Authors: Sidra L Speaker; Radhika Rastogi; Tamara A Sussman; Bo Hu; Anita D Misra-Hebert; Michael B Rothberg Journal: J Gen Intern Med Date: 2021-01-15 Impact factor: 5.128
Authors: Sean Mahoney; Adam Bradley; Logan Pitts; Stephanie Waletzko; Sheria G Robinson-Lane; Timothy Fairchild; Donna J Terbizan; Ryan McGrath Journal: Int J Environ Res Public Health Date: 2020-06-30 Impact factor: 3.390